AI-generated analysis. Always verify with the original filing.
On February 20, 2026, NovaBay Pharmaceuticals, Inc. filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation, triggering disclosures under Items 3.03 and 5.03. Exhibit 3.1 contains the amendment document.
Event Type
Disclosure
Mandatory
Variant
8-K
. Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year On February 20, 2026, NovaBay Pharmaceuticals, Inc. (the “Company”) filed a
Financial Statements and Exhibits (d) Exhibits . Exhibit No. Description 3.1 Certificate of Amendment to the Amended and Restated Certificate of Incorporation,